Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Spectrum of leprosy among suspected cases attending a teaching hospital in Western Rajasthan, India.

Kalita J, Nag V, Yedale K. Journal of family medicine and primary care. 2020; 9 (6) : 2781-2784.
Download PDF
Publication

Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options.

Mungroo M, Khan N, Siddiqui R. Microbial pathogenesis. 2020;
Publication

Age, gender and BCG vaccination status as risk factors for Leprosy in endemic areas of northern Brazil.

Lima LNGC, Letícia Pinto Paz J, Silvestre MDPSCA, et al. Research Square. 2020;
Download PDF
Publication

BCG vaccination: Effects on the patterns of pediatric leprosy

Sarkar S, Sarkar T, Patra A, et al. Medknow. Journal of Family Medicine and Primary Care. 2020; 9 (7) : 3673.
Download PDF
Publication

CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION

Novita BD. Jurnal Widya Medika. 2020; 6 (1) : 65-71.
Publication

Anti-Leprosy Vaccine (Hansen’s Disease Vaccine)

Packyanathan J, Packyanathan I. Springer. Advances in Pharmaceutical Biotechnology. 2020;
Publication

Leprosy: Treatment and Management of Complications.

Maymone M, Venkatesh S, Laughter M, et al. Journal of the American Academy of Dermatology. 2020;
Publication

Preventing Leprosy: Epidemiological and immunological aspects of chemo- and immunoprophylaxis in leprosy patients’ contacts

Richardus R. Leiden University. Leiden University of Medical Center. 2020;
Download PDF
Publication

BCG: a vaccine with multiple faces.

Yamazaki-Nakashimada M, Unzueta A, Gámez-González L, et al. Human vaccines & immunotherapeutics. 2020;
Publication

Prevention of transmission of leprosy: The current scenario.

Palit A, Kar HK. Indian journal of dermatology, venereology and leprology. 2020; 86 (2) : 115-123.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 7
  • Next page ››
Subscribe to Immunoprophylaxis / Vaccine

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD